 |
Journal articles
Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission
Abstract : We conducted a multicenter, retrospective cohort study of hospitalized patients with serologically proven nephropathia epidemica (NE) living in Ardennes Department, France, during 2000-2014 to develop a bioclinical test predictive of severe disease. Among 205 patients, 45 (22.0%) had severe NE. We found the following factors predictive of severe NE: nephrotoxic drug exposure (p = 0.005, point value 10); visual disorders (p = 0.02, point value 8); microscopic or macroscopic hematuria (p = 0.04, point value 7); leukocyte count >10 × 109 cells/L (p = 0.01, point value 9); and thrombocytopenia <90 × 109/L (p = 0.003, point value 11). When point values for each factor were summed, we found a score of <10 identified low-risk patients (3.3% had severe disease), and a score >20 identified high-risk patients (45.3% had severe disease). If validated in future studies, this test could be used to stratify patients by severity in research studies and in clinical practice.
Cited literature [45 references]
https://hal-pasteur.archives-ouvertes.fr/pasteur-01834306
Contributor : Jean-Marc Reynes Connect in order to contact the contributor
Submitted on : Tuesday, July 10, 2018 - 2:25:25 PM
Last modification on : Wednesday, November 3, 2021 - 4:55:09 AM
Long-term archiving on: : Thursday, October 11, 2018 - 12:50:09 PM
Contributor : Jean-Marc Reynes Connect in order to contact the contributor
Submitted on : Tuesday, July 10, 2018 - 2:25:25 PM
Last modification on : Wednesday, November 3, 2021 - 4:55:09 AM
Long-term archiving on: : Thursday, October 11, 2018 - 12:50:09 PM
File
17-2160.pdf
Publisher files allowed on an open archive
Licence
Distributed under a Creative Commons Attribution 4.0 International License